» Articles » PMID: 27613133

MicroRNA and Metastasis

Overview
Journal Adv Cancer Res
Publisher Elsevier
Specialty Oncology
Date 2016 Sep 11
PMID 27613133
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Noncoding RNAs are important regulatory molecules of cellular processes. MicroRNAs (miRNAs) are small noncoding RNAs that bind to complementary sequences in the 3' untranslated region of target mRNAs, leading to degradation of the target mRNAs and/or inhibition of their translation. Some miRNAs are essential for normal animal development; however, many other miRNAs are dispensable for development but play a critical role in pathological conditions, including tumorigenesis and metastasis. miRNA genes often reside at fragile chromosome sites and are deregulated in cancer. Some miRNAs function as oncogenes or tumor suppressors, collectively termed "oncomirs." Specific metastasis-regulating miRNAs, collectively termed "metastamirs," govern molecular processes and pathways in malignant progression in either a tumor cell-autonomous or a cell-nonautonomous manner. Recently, exosome-transferred miRNAs have emerged as mediators of the tumor-stroma cross talk. In this chapter, we focus on the functions, mechanisms of action, and therapeutic potential of miRNAs, particularly oncomirs and metastamirs.

Citing Articles

tRNA, yRNA, and rRNA fragment excisions do not involve canonical microRNA biogenesis machinery.

Godang N, Nguyen A, DeMeis J, Paudel S, Campbell N, Barnes K MicroPubl Biol. 2024; 2024.

PMID: 39634108 PMC: 11615671. DOI: 10.17912/micropub.biology.001332.


Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.

Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.

PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.


miR-3154 promotes glioblastoma proliferation and metastasis via targeting TP53INP1.

Lin X, Wu Q, Lei W, Wu D, Sheng J, Liang G Cell Div. 2024; 19(1):30.

PMID: 39487468 PMC: 11529598. DOI: 10.1186/s13008-024-00134-w.


Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review).

Xie W, Wang Z, Wang J, Wang X, Guan H Int J Oncol. 2024; 65(1).

PMID: 38757364 PMC: 11155714. DOI: 10.3892/ijo.2024.5655.


Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases.

Ham-Karim H, Negm O, Ahmad N, Ilyas M Cancer Cell Int. 2023; 23(1):192.

PMID: 37670299 PMC: 10478430. DOI: 10.1186/s12935-023-03020-7.